EMMBRAce Project
With exciting NICE approvals of Teclistamab and Eranatamab, we want to ensure patients with Myeloma across the UK have fair access to these treatments. However, there are challenges to delivery. We are a group of NHS haematology healthcare professionals across the UK that are working to support hospitals to deliver this new therapy to patients.
This website contains resources to support the development of services to provide bispecific antibodies to patients with Multiple Myeloma. This project is ongoing and resources will be added as they are developed. We aim to develop and provide:
- Guidance on service development
- Templates for referrals
- Educational resources
About us
This project is being led and overseen by a steering group involving a multidisciplinary team of NHS doctors, nurses and pharmacists from across the UK alongside charity and industry partners.
Contact us
You can contact the team at: Uclh.emmbrace.queries@nhs.net
Image credits: Photos designed by Freepik